Kellogg Co.’s stock price rose over 5 percent immediately following its announcement that it will be splitting into three companies, focused on snacks, plant-based foods, and breakfast cereal.
Wall Street analysts claim that even though the stock dropped again after the Kellogg announcement, food equities as a whole increased.
The method employed by Kellogg fits into a developing pattern of increased snack intake. According to Mintel data, half of the consumers between the ages of 35 and 54 believe that snacking is healthier than eating three meals regularly throughout the day.
Sales for Kellogg's snacks division were $11.4 billion last year, much above those of the other two spinoff units.
The breakup of Kellogg has also sparked interest in comparable actions among large food corporations with broad product lines. As smaller units become more nimble to adapt to trends and events, such actions typically acquire flexibility.
The trade-off is that, in some situations, the smaller businesses do not profit as much from economies of scale as the larger ones did.


Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
Wikipedia Pushes for AI Licensing Deals as Jimmy Wales Calls for Fair Compensation
IMF Deputy Dan Katz Visits China as Key Economic Review Nears
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
Momenta Quietly Moves Toward Hong Kong IPO Amid Rising China-U.S. Tensions
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows 



